PAPP-A TechNotes

Pregnancy-associated plasma protein-A (PAPP-A) is a metalloprotease that belongs to the metzincin superfamily of zinc peptidases. Its main substrate is insulin-like growth factor binding protein (IGFPB) 4. This cleavage causes release of bound IGF, which plays an important role in promoting cell differentiation and proliferation. PAPP-A was first identified from the serum of pregnant women, hence its name. Later, it was shown to be expressed in multiple tissues.

Two forms of PAPP-A

Heterotetrameric PAPP-A (htPAPP-A) is a screening marker for Down syndrome. htPAPP-A level in maternal serum increases with gestational age until term. If the concentration of htPAPP-A in the first trimester is markedly decreased, this indicates a higher risk of Down syndrome (1).

htPAPP-A is a protein complex consisting of two PAPP-A subunits and two proforms of eosinophil basic proteins (proMBP) covalently linked to each other. proMBP has been shown to inhibit the protease activity of PAPP-A in this heteromeric complex (2).

Homodimeric PAPP-A (dPAPP-A) is abundantly expressed in unstable coronary atherosclerotic plaques (3). dPAPP-A circulates as a homodimer and not in complex with proMBP. Based on several studies dPAPP-A has been considered to be a promising marker of plaque destabilization in patients with acute coronary syndrome (ACS). Unfortunately, dPAPP-A assays have been shown to also detect htPAPP-A, the Down syndrome marker not related to atherosclerotic plaques. In order to prevent this, a dPAPP-A assay should be designed so that it only recognizes dPAPP-A and does not cross-react with htPAPP-A.

Another limitation to the use of dPAPP-A as a cardiac marker is the fact that the measurements were shown to be affected by heparin, an anti-coagulation agent often used as part of the treatment procedure with patients suffering from acute myocardial infarction. So in order to use dPAPP-A as a cardiac biomarker the heparin injections should be taken into account when analyzing the samples.

A promising surrogate marker for dPAPP-A is its main substrate IGFBP-4. For more information, please see our IGFBP-4 TechNotes.

Reagents for immunoassay development

We provide monoclonal antibodies (MAbs) specific to PAPP-A and proMBP that allow for the development of highly sensitive, quantitative htPAPP-A immunoassays. We also provide reagents for the development of dPAPP-A specific assay. In addition, we provide htPAPP-A antigen purified from retroplacental blood. HyTest is the largest global supplier of this product.

References:

Search PAPP-A references from PubMed.

Related products:

See other cardiac markers and blood coagulation products
See other fertility products

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!